We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$6.41B
AUM Growth
+$438M
Cap. Flow
+$262M
Cap. Flow %
4.09%
Top 10 Hldgs %
5.91%
Holding
1,357
New
244
Increased
460
Reduced
351
Closed
237

Top Buys

Rank Stock Value
1
ENS icon
EnerSys
ENS
+$23.6M
2
SM icon
SM Energy
SM
+$20.1M
3
KMPR icon
Kemper
KMPR
+$20.1M
4
FRSH icon
Freshworks
FRSH
+$19.9M
5
SBRA icon
Sabra Healthcare REIT
SBRA
+$19.3M

Top Sells

Rank Stock Value
1
FIX icon
Comfort Systems
FIX
+$37.2M
2
CRDO icon
Credo Technology Group
CRDO
+$23.6M
3
INSM icon
Insmed
INSM
+$20.8M
4
GPI icon
Group 1 Automotive
GPI
+$20.6M
5
WK icon
Workiva
WK
+$18.9M

Sector Composition

Rank Sector Weight
1 Industrials 17.1%
2 Technology 16.08%
3 Healthcare 14.95%
4 Financials 14.43%
5 Consumer Discretionary 12.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPSN icon
1101
LivePerson
LPSN
$18.6M
$78K ﹤0.01%
+20,095
New +$112K
PMVP icon
1102
PMV Pharmaceuticals
PMVP
$70.9M
$78K ﹤0.01%
62,020
IPSC icon
1103
Century Therapeutics
IPSC
$384M
$76K ﹤0.01%
+76,800
New +$46.8K
FHTX icon
1104
Foghorn Therapeutics
FHTX
$298M
$75K ﹤0.01%
+13,928
New +$63.1K
INNV icon
1105
InnovAge Holding
INNV
$1.51B
$74K ﹤0.01%
+14,265
New +$75K
AMWL icon
1106
American Well
AMWL
$187M
$69K ﹤0.01%
+14,052
New +$67.8K
ONL
1107
Orion Office REIT
ONL
$148M
$68K ﹤0.01%
30,279
+5,570
+23% +$13.1K
AP icon
1108
Ampco-Pittsburgh
AP
$169M
$67K ﹤0.01%
+12,570
New +$34.8K
ARQ icon
1109
Arq
ARQ
$88.4M
$66K ﹤0.01%
20,170
+8,490
+73% +$41.5K
CVU icon
1110
CPI Aerostructures
CVU
$59.7M
$65K ﹤0.01%
+16,438
New +$45K
ZNTL icon
1111
Zentalis Pharmaceuticals
ZNTL
$324M
$65K ﹤0.01%
48,496
GRWG icon
1112
GrowGeneration
GRWG
$84.1M
$64K ﹤0.01%
+42,716
New +$70.1K
VNCE icon
1113
Vince Holding Corp
VNCE
$79.5M
$61K ﹤0.01%
14,915
-2,105
-12% -$6.46K
KLTR icon
1114
Kaltura
KLTR
$217M
$60K ﹤0.01%
36,460
BWEN icon
1115
Broadwind
BWEN
$121M
$58K ﹤0.01%
+20,640
New +$54.2K
CMTG icon
1116
Claros Mortgage Trust
CMTG
$308M
$58K ﹤0.01%
19,027
-364,659
-95% -$1.19M
CDLX icon
1117
Cardlytics
CDLX
$22.9M
$48K ﹤0.01%
4,133
SPWH icon
1118
Sportsman's Warehouse
SPWH
$44.9M
$39K ﹤0.01%
+26,430
New +$57.5K
OABI icon
1119
OmniAb
OABI
$296M
$38K ﹤0.01%
+20,498
New +$35.6K
ORMP icon
1120
Oramed Pharmaceuticals
ORMP
$168M
$34K ﹤0.01%
+12,068
New +$31.1K
ACHC icon
1121
Acadia Healthcare
ACHC
$3.15B
-99,200
Closed -$2.46M
ACRS icon
1122
Aclaris Therapeutics
ACRS
$763M
-65,630
Closed -$125K
ACRV icon
1123
Acrivon Therapeutics
ACRV
$71.5M
-44,648
Closed -$81K
ACT icon
1124
Enact Holdings
ACT
$6.33B
-45,496
Closed -$1.74M
ADEA icon
1125
Adeia
ADEA
$2.97B
-43,260
Closed -$727K

Similar funds

Algert Global's Q4 2025 Portfolio in Review

As of Q4 2025, Algert Global held 1,357 positions worth $6.41B, up 7.3% from $5.98B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Algert Global deployed $262M of net new capital in Q4 2025, opening 244 new positions and adding to 460 existing holdings. Its largest new stake was Roivant Sciences: 706,554 shares worth $15.3M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Comfort Systems, an estimated $37.2M trimmed.

  • Algert Global's largest Q4 2025 buy was Roivant Sciences: 706,554 shares worth $15.3M.
  • Algert Global added most to EnerSys in Q4 2025, an estimated $23.6M increase.
  • Algert Global's biggest Q4 2025 reduction was Comfort Systems, cutting an estimated $37.2M.
  • Algert Global fully exited Insmed in Q4 2025, selling an estimated $20.8M.
  • Algert Global's ten largest holdings make up 5.9% of its $6.41B portfolio in Q4 2025.
  • Algert Global opened 244 new positions and closed 237 in Q4 2025.
  • Algert Global's portfolio value rose 7.3% quarter-over-quarter to $6.41B.

Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.